Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · IEX Real-Time Price · USD
2.420
-0.150 (-5.84%)
At close: Jul 2, 2024, 4:00 PM
2.479
+0.059 (2.44%)
After-hours: Jul 2, 2024, 6:27 PM EDT
Revance Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$12.00
Upside
+395.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +354.55% | May 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +230.58% | May 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $20 → $11 | Buy | Reiterates | $20 → $11 | +354.55% | May 10, 2024 |
| Mizuho | Mizuho | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +230.58% | May 10, 2024 |
| Needham | Needham | Strong Buy Maintains $18 → $12 | Strong Buy | Maintains | $18 → $12 | +395.87% | May 10, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +271.90% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +395.87% | Feb 29, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $20 | Buy | Maintains | $42 → $20 | +726.45% | Feb 29, 2024 |
| Needham | Needham | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +643.80% | Feb 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $12 | Strong Buy | Maintains | $15 → $12 | +395.87% | Feb 23, 2024 |
| Barclays | Barclays | Buy Maintains $35 → $10 | Buy | Maintains | $35 → $10 | +313.22% | Jan 29, 2024 |
| Mizuho | Mizuho | Strong Buy → Hold Downgrades $16 → $9 | Strong Buy → Hold | Downgrades | $16 → $9 | +271.90% | Jan 29, 2024 |
| Needham | Needham | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +726.45% | Jan 9, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $30 → $8 | Strong Buy → Hold | Downgrades | $30 → $8 | +230.58% | Jan 9, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $35 → $16 | Strong Buy | Maintains | $35 → $16 | +561.16% | Nov 22, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $44 → $42 | Buy | Maintains | $44 → $42 | +1,635.54% | Nov 9, 2023 |
| Needham | Needham | Strong Buy Maintains $35 → $25 | Strong Buy | Maintains | $35 → $25 | +933.06% | Nov 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $41 → $15 | Strong Buy | Maintains | $41 → $15 | +519.83% | Nov 6, 2023 |
| Barclays | Barclays | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +1,346.28% | Oct 23, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $25 → $12 | Hold | Maintains | $25 → $12 | +395.87% | Oct 11, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $38 → $33 | Strong Buy | Maintains | $38 → $33 | +1,263.64% | Sep 21, 2023 |